Skip to main content

Advertisement

SpringerLink
Log in

Modafinil in the Treatment of Debilitating Fatigue in Primary Biliary Cirrhosis: A Clinical Experience

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Modafinil may be a potentially effective treatment for primary biliary cirrhosis (PBC)-related fatigue. About 42 patients were given a 3-day trial of 100–200 mg modafinil. Response was defined as increased energy, decreased somnolence and sleep requirements, and improved daily function. Patients with positive responses were continued indefinitely on the medication. During the initial trial period, 31 (73%) patients had complete response and continued to take the medication. Eleven (26%) had no response. In long-term follow-up (average 17.7 months), 25 (81%) patients continued to take 100–200 mg modafinil daily. Some required an increased dosage and some took the medication as needed. Four (12%) patients stopped the medication because of side-effects or reduced efficacy; one patient (3%) stopped due to medication cost and one (3%) due to resolution of fatigue. Side-effects included insomnia, nausea, nervousness, and headaches. Modafinil appears to be a safe, effective treatment for PBC-related fatigue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1261–1273.

    Article  PubMed  CAS  Google Scholar 

  2. Borg PC, Fekkes D, Vrolijk JM, van Buuren HR. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis. BMC Gastroenterol. 2005;5:11.

    Article  PubMed  CAS  Google Scholar 

  3. Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis. 2003;7(4):879–900.

    Article  PubMed  Google Scholar 

  4. Ahboucha S, Pomier-Layrargues G, Vincent C, et al. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis. Neurochem Int. 2008;52(4–5):569–574.

    Article  PubMed  CAS  Google Scholar 

  5. Jones EA, Bergasa NV. The pathogenesis and treatment of pruritus and fatigue in patients with PBC. Eur J Gastroenterol Hepatol. 1999;11(6):623–631.

    Article  PubMed  CAS  Google Scholar 

  6. Gong Y, Huang Z, Christensen E, Gluud C. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol. 2007;102(8):1799–1807.

    Article  PubMed  CAS  Google Scholar 

  7. Talwalkar JA, Donlinger JJ, Gossard AA, Keach JC, Jorgensen RA, Lindor KD. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial. Dig Dis Sci. 2006;51(11):1985–1991.

    Article  PubMed  CAS  Google Scholar 

  8. Borg PC, van Os E, van den Broek WW, Hansen BE. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial. BMC Gastroenterol. 2004;4:13.

    Article  PubMed  CAS  Google Scholar 

  9. Battezzati PM, Zuin M, Crosignani A, et al. Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. Aliment Pharmacol Ther. 2001;15(9):1427–1434.

    Article  PubMed  CAS  Google Scholar 

  10. Babatin MA, Sanai FM, Swain MG. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Aliment Pharmacol Ther. 2006;24(5):813–820.

    Article  PubMed  CAS  Google Scholar 

  11. Theal JJ, Toosi MN, Girlan L, et al. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue. Hepatology. 2005;41(6):1305–1312.

    Article  PubMed  CAS  Google Scholar 

  12. Kaplan MM, Schmid C, Provenzale D, Sharma A, Dickstein G, McKusick A. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis. Gastroenterology. 1999;117(5):1173–1180.

    Article  PubMed  CAS  Google Scholar 

  13. Kaplan MM, Bonis PA. Modafinil for the treatment of fatigue in primary biliary cirrhosis. Ann Intern Med. 2005;143(7):546–547.

    PubMed  Google Scholar 

  14. Jones DE, Newton JL. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;25(4):471–476.

    Article  PubMed  CAS  Google Scholar 

  15. Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology. 2006;44(1):91–98.

    Article  PubMed  Google Scholar 

  16. Scammell TE, Matheson J. Modafinil: a novel stimulant for the treatment of narcolepsy. Expert Opin Investig Drugs. 1998;7(1):99–112.

    Article  PubMed  CAS  Google Scholar 

  17. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000;14(1):53–60.

    Article  PubMed  CAS  Google Scholar 

  18. Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF. Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol. 2002;13(2):105–115.

    PubMed  CAS  Google Scholar 

  19. Jasinski DR, Kovacević-Ristanović R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol. 2000;23(3):149–156.

    Article  PubMed  CAS  Google Scholar 

  20. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2007;33:1477–1502.

    Article  PubMed  CAS  Google Scholar 

  21. Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ. Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin Neuropharmacol. 2003;26(5):252–257.

    Article  PubMed  CAS  Google Scholar 

  22. Czeisler CA, Walsh JK, Roth T, et al. US Modafinal in shift work sleep disorder associated with shift-work sleep disorder. N Engl J Med. 2005;353(5):476–486.

    Article  PubMed  CAS  Google Scholar 

  23. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28(4):464–471.

    PubMed  Google Scholar 

  24. Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS; a randomized placebo-controlled double-blind study. Neurology. 2005;64(7):1139–1143.

    PubMed  CAS  Google Scholar 

  25. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatr. 2005;76(12):1636–1639.

    Article  PubMed  CAS  Google Scholar 

  26. Thase ME, Fava M, De Battista C, Arora S, Hughes RJ. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr. 2006;11(2):93–102.

    PubMed  Google Scholar 

  27. Schwartz JR, Feldman NT. Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. J Neuropsychiatry Clin Neurosci. 2005;17:405–412.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Tufts Medical Center, P.O. Box 233, Boston, MA, 02111, USA

    S. Ian Gan, Mariana de Jongh & Marshall M. Kaplan

Authors
  1. S. Ian Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariana de Jongh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marshall M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marshall M. Kaplan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ian Gan, S., de Jongh, M. & Kaplan, M.M. Modafinil in the Treatment of Debilitating Fatigue in Primary Biliary Cirrhosis: A Clinical Experience. Dig Dis Sci 54, 2242–2246 (2009). https://doi.org/10.1007/s10620-008-0613-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0613-3

Keywords

Search

Navigation